Enrollment of 127 of 150 individuals in the scientific trial analyzing Trimesta in women suffering from relapsing-remitting multiple sclerosis, by March 2, 2011. The randomized, double-blind, placebo-controlled medical trial happens to be underway at 15 centers in the usa. We anticipate full enrollment by the next half of 2011. Functions Execution of an agreement for the sale of around 2.85 million shares of common stock at $1.40 per share to new institutional investors in a registered direct offering for gross proceeds of $4 million. Investors received warrants to purchase approximately 1 also.42 million shares of common stock at a fitness price of $2.00 per share and are exercisable for an interval of 13 months. Appointment of George J. Brewer, M.D., the Morton S. And Henrietta Sellner Emeritus Professor of Individual Genetics and Internal Medication at the University of Michigan, mainly because Senior Vice President of Research & Development, following the unexpected passage of David A.Another MRI scan showed enlargement of the lesion . Once again, a PCR assay for JC virus DNA in the cerebrospinal fluid was negative. However, PML was suspected based on the patient’s clinical program and MRI findings. Treatment of PML Plasma exchange was initiated to eliminate natalizumab in order to restore immune function, with five treatments every second day.11 After the last two plasma-exchange remedies, 1000 ml of extra plasma was added. The plasma-exchange treatments significantly decreased the focus of natalizumab in the patient’s serum, from 14. During plasma exchange and the 5 several weeks that implemented, the patient’s symptoms continuing to worsen. Samples of the patient’s cerebrospinal fluid that had been obtained in July 2008, prior to the initiation of plasma-exchange treatment, had been delivered to the Laboratory of Molecular Medication and Neuroscience at the National Institute of Neurological Disorders and Stroke for quantitative PCR testing for JC virus DNA.